Price T Rowe Associates Inc Medicinova Inc Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Medicinova Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 20,700 shares of MNOV stock, worth $32,085. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,700
Previous 20,700
-0.0%
Holding current value
$32,085
Previous $31,000
3.23%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding MNOV
# of Institutions
34Shares Held
4.69MCall Options Held
7.2KPut Options Held
3.8K-
Essex Woodlands Management, Inc. The Woodlands, TX1.11MShares$1.71 Million0.52% of portfolio
-
Black Rock Inc. New York, NY695KShares$1.08 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA623KShares$966,1660.0% of portfolio
-
Geode Capital Management, LLC Boston, MA459KShares$711,0850.0% of portfolio
-
Citigroup Inc448KShares$694,3330.0% of portfolio
About MEDICINOVA INC
- Ticker MNOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,046,200
- Market Cap $76M
- Description
- MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...